Aficamten shows significant benefits over metoprolol in treating symptomatic obstructive HCM, potentially changing first-line therapy approaches.
Pablo Garcia-Pavia, MD, PhD
Advertisement
Dr. Pablo García-Pavia is the Head of the Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, at the Hospital Universitario Puerta de Hierro in Madrid, Spain.
Articles by Pablo Garcia-Pavia, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study
2
Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B
3
Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial
4
Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs
5